| One billion hiPSC-cardiomyocytes: Upscaling engineered cardiac tissues to create high cell density therapies for clinical translation in heart regeneration KD Dwyer, RJ Kant, AH Soepriatna, SM Roser, MC Daley, SA Sabe, ... Bioengineering 10 (5), 587, 2023 | 5 | 2023 |
| Abstract P1129: Directing Revascularization In Vivo With Local Controlled Release Of An Optimized Angiogenic Growth Factor Cocktail A Minor, S Roser, R Kant, K Zahiri, C Polucha, KL Coulombe Circulation Research 133 (Suppl_1), AP1129-AP1129, 2023 | | 2023 |
| Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue KLK Coulombe, S Roser, F Munarin, A Minor US Patent App. 17/862,962, 2023 | | 2023 |
| Abstract P1142: Engineering Vascular Therapies With Angiogenic Factors For Cardiac Regeneration And Tissue Remodeling A Minor, S Roser, K Zahiri, E Song, M Kobayashi, C Polucha, ... Circulation Research 131 (Suppl_1), AP1142-AP1142, 2022 | | 2022 |
| Abstract P1141: Heparinized Alginate And Collagen-based Hydrogels Enhance Localized Vascularization In Ischemic Tissue SM Roser, A Minor, C Polucha, KL Coulombe Circulation Research 131 (Suppl_1), AP1141-AP1141, 2022 | | 2022 |
| Engineering Cardiac Regenerative Therapies To Stimulate Angiogenesis And Tissue Remodeling AJ Minor, SM Roser, K Zahiri, E Song, M Kobayashi, C Polucha, ... TISSUE ENGINEERING PART A 28, 373-373, 2022 | | 2022 |
